Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Users transitioning from tirzepatide to retatrutide should monitor for new or different injection site reaction patterns during the switch
This separation is part of why many repeat research customers cite consistency as a reason they continue sourcing this spray format from PSPeptides
Based on published clinical trial data: Nausea and mild digestive discomfort are the most common, especially in the first few weeks Reduced appetite (which is also a desired effect) can occasionally cause fatigue if caloric intake drops too quickly Injection site reactions are possible but generally mild and transient No serious organ-level safety signals have been identified in trials to date This is precisely why access through a licensed, physician-supervised compounding pharmacy like CureCell is so important
To further address such questions, we believe, there is a need for large (multi-center) RCTs, however, the rarity of HO, make such RCTs difficult and time costly
